Insulin detemir. Novo Nordisk
Barlocco, D.
Current Opinion in Investigational Drugs 4(4): 449-454
2003
ISSN/ISBN: 1472-4472 PMID: 12808886 Document Number: 561362
Insulin detemir (NN-304) is a soluble, long-acting insulin analog being developed by Novo Nordisk for the potential treatment of type 1 and 2 diabetes. As of February 2003, Novo Nordisk was expecting both US and EU approval in the first half of 2004. In December 2002, Novo Nordisk submitted an NDA to the FDA and an NDS to the Canadian Biologics & Genetics Therapeutic Directorate for the approval of insulin detemir for the treatment of diabetes mellitus.
Document emailed within 1 workday
Related Documents
Kalra, S. 2013: Newer basal insulin analogues: degludec, detemir, glargine Jpma. Journal of the Pakistan Medical Association 63(11): 1442-1444Pan, C.-y.; Ji, L.-n.; Lu, J.-m.; Yang, W.-y.; Zhou, Z.-g.; Zou, D.-j.; Ji, Q.-h.; Han, P.; Liu, J.; Li, Q.; Su, B.-l.; Li, Y.-b.; Gao, Z.-n.; Wang, P.-h.; Yin, S.-n.; Dong, Y.-h.; Yang, T.; Sun, K.; Li, H.; Hong, X.; Lin, J.; Shi, J.-m.; Yang, X.-J.; Fang, H.; Yan, X.-d. 2012: The baseline characteristics of patients with type 2 diabetes initiating insulin detemir : the Chinese cohort from the SOLVE(TM) study Zhonghua Nei Ke Za Zhi 51(12): 957-961
Liebl, A.; Wilhelm, B.; Kaiser, M. 2012: Once daily insulin detemir in patients with type 2 diabetes: results of German centers in a 6-month international observational study (SOLVE) MMW Fortschritte der Medizin 154 Suppl. 4: 102-109
Pan, C.; Ji, L.; Lu, J.; Yang, W.; Zhou, Z. 2015: Effectiveness and safety of initiation of once-daily insulin detemir in Chinese patients with type 2 diabetes previously treated with different quantities of oral anti-diabetic drugs: subgroup analysis of the Chinese SOLVE™ Study Zhonghua Nei Ke Za Zhi 54(7): 612-617
Skrubbeltrang, F. 1961: Hovedlinier i nordisk jordpolitik. Principal traits in nordic land policy Nordisk Kontakt. Stockholm 2: 121-123
Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452
Pan, C.-y.; Ji, L.-n.; Lu, J.-m.; Yang, W.-y.; Zhou, Z.-g.; Zou, D.-j.; Ji, Q.-h.; Han, P.; Liu, J.; Li, Q.; Su, B.-l.; Li, Y.-b.; Gao, Z.-n.; Wang, P.-h.; Yin, S.-n.; Dong, Y.-h.; Yang, T.; Sun, K.; Li, H.; Hong, X.; Lin, J.; Shi, J.-m.; Yang, X.-j.; Fang, H.; Yan, X.-d. 2013: The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study Zhonghua Nei Ke Za Zhi 52(1): 11-15
Klöppel, G.; Freytag, G.; Graesslin, D. 1973: Preparation of monomer insulin components and insulin-like contaminants from crystalline insulin by isoelectric focusing technique Acta Endocrinologica. Supplementum 173: 58
Chang, T.C.; Wang, L.M.; Cheng, C.Y.; Kuo, H.F.; Liu, P.C.; Ho, L.T. 1990: The action of gliclazide on insulin secretion and insulin sensitivity in non-obese non-insulin dependent diabetic patients Zhonghua Yi Xue Za Zhi 46(2): 79-85
De Meijer, P.H.; Lutterman, J.A. 1990: Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin Netherlands Journal of Medicine 36(1-2): 4-12
Fernández Landó, L.; Massari, F.; Oviedo, A.; Jiang, H. 2012: Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes Medicina 72(3): 235-242
Hildebrandt, P. 1991: Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors Danish Medical Bulletin 38(4): 337-346
Beck-Nielsen, H.; Henriksen, J.E.; Alford, F.; Hother-Nielson, O. 1996: In vivo glucose metabolism, insulin secretion and, insulin action in Europids with non-insulin-dependent diabetes mellitus (NIDDM) and their first-degree relatives Diabetic Medicine: a Journal of the British Diabetic Association 13(9 Suppl 6: S78-S84
Lepore, G.; Dodesini, A.R.; Nosari, I.; Trevisan, R. 2004: Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study Diabetes Nutrition and Metabolism 17(2): 84-89
De Meyts, P. 1994: Insulin receptors and mechanism of action of insulin and of insulin-like growth factors Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 149(3-4): 181-190; Discussion: 190-194
Mohan, V.; Das, A.K.; Joshi, S.R. 2015: Insulin Degludec/Insulin Aspart: a Novel Co-formulation for Insulin Intensification Journal of the Association of Physicians of India 63(5 Suppl): 6-7
Okada, Y. 2012: New information of oral insulin, nasal insulin and inhaled insulin Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 678-681
Imachi, H.; Murao, K. 2012: Insulin, glucagon, insulin autoantibody (IAA), insulin receptor antibody Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 442-445
Yanagisawa, K. 1992: A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal Hokkaido Journal of Medical Science 67(1): 81-88
Jungmann, E. 1997: From human insulin to designer insulin. Why insulin analogs? Fortschritte der Medizin 115(12): 40-41